SCHEMBL20329604

SCHEMBL20329604

O=C1CCN(I)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11703676 0.72
SCHEMBL31199061 0.68
SCHEMBL3182138 0.68
SCHEMBL7746034 0.68
SCHEMBL1586116 0.68
SCHEMBL18019315 0.68
SCHEMBL9600797 0.67
SCHEMBL11568357 0.67 CRBN (0.55)
SCHEMBL3340184 0.65 CRBN (0.39)
Succinimide SCHEMBL3805994 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283610-A1 COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS BIOGEN MA INC. (US) 2023-01-12 WO disclosed
EP-3558394-B1 TETRAAZABICYCLO-MACROCYCLE BASED MANGANESE CHELATE COMPOUNDS SUITABLE AS MRI IMAGING AGENTS GE HEALTHCARE AS (NO) 2020-06-03 EP disclosed
WO-2018115314-A1 TETRAAZABICYCLO-MACROCYCLE BASED MANGANESE CHELATE COMPOUNDS SUITABLE AS MRI IMAGING AGENTS GE HEALTHCARE AS (NO) 2018-06-28 WO disclosed